Modal Developmental Aspects of Schizophrenia Across the Life Span

  • Elaine Walker
  • Dana Davis
  • Jay Weinstein
  • Tammy Savoie
  • Kathleen Grimes
  • Kym Baum
Part of the Series in Psychopathology book series (PSYCHOPATHOLOGY)


One of the most well-established features of the schizophrenic syndrome is its modal age at onset; namely, late adolescence/early adulthood (Loranger, 1984). Because of the apparent salience of this developmental period for the emergence of psychotic symptoms, researchers in the field have focused a great deal of attention on the psychosocial and biological events that characterize it. A widely held assumption has been that certain unique aspects of this period must be playing a role in triggering the expression of psychotic symptoms. Most recently, with the increasing emphasis on biological origins of psychopathology, several writers have pointed out the potential triggering role of postpubescent maturational events in the central nervous system (Benes, 1989, 1991; Feinberg, 1982–1983; Weinberger, 1987).


Facial Expression Negative Symptom Schizophrenic Patient Tardive Dyskinesia Positive Symptom 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abdel-Dayem, H.M., El-Hilu, S., Sehweil, A., Higazi, B., Jahan, S., Salhat, M., & Al-Mohannadi, S. (1990). Cerebral perfusion changes in schizophrenic patients using Tc-99m Hexamethylpropylene Amineoxime (HMPAO). Clinical Nuclear Medicine, 15, 468–472.PubMedGoogle Scholar
  2. Altshuler, L.L., Conrad, A., Kovelman, J.A., & Scheibel, A. (1987). Hippo- campal pyramidal cell orientation in schizophrenia. Archives of General Psychiatry, 44, 1094–1098.PubMedGoogle Scholar
  3. Andreasen, N.C., Ehrardt, J.C., Swayze, V.W., Alliger, R.J., Yuh, W.T.C., Cohen, G., & Zeibell, S. (1990). Magnetic resonance imaging of the brain in schizophrenia. Archives of General Psychiatry, 47, 35–44.PubMedGoogle Scholar
  4. Andreasen, N.C., & Olsen, S. (1982). Negative versus positive schizophrenia. Archives of General Psychology, 39, 789–794.Google Scholar
  5. Anzai, N., Okazaki, Y., Miyauchi, M., Harada, S.I., Kanou, Y., Sasaki, T., Kumagai, N., Shikiba, N., Iwanami, A., Iadi, S., Hiramatsu, K.I., Niwa, S.I., & Ohta, M. (1988). Early neuroleptic medication within one year after onset can reduce risk of later relapses in schizophrenic patients. Annual Report Pharmacopsychiatric Research Foundation, 19, 258–265.Google Scholar
  6. Aylward, E., Walker, E., & Bettes B. (1984). Intelligence in schizophrenia: Meta-analysis of the research. Schizophrenia Bulletin, 10 (3), 430–459.PubMedGoogle Scholar
  7. Bardenstein, K.K., & McGlashan, T.H. (1990). Gender differences in affective, schizoaffective and schizophrenic disorders. A review. Schizophrenia Research, 3, 159–172.PubMedGoogle Scholar
  8. Barthell, C.N., & Holmes, D.S. (1968). High school yearbooks: A nonreactive measure of social isolation in graduates who later became schizophrenic. Journal of Abnormal Psychology, 73 (4), 313–316.PubMedGoogle Scholar
  9. Benes, F.M. (1989). Myelination of cortical hippocampal relays during late adolescence. Schizophrenia Bulletin, 15, 585–594.PubMedGoogle Scholar
  10. Benes, F.M. (1991). Toward a neurodevelopmental understanding of schizophrenia and other psychiatric disorders. In D. Cicchetti & S.L. Toth (Eds.), Rochester Symposium on Developmental Psychopathology, 3, 161–184.Google Scholar
  11. Bland, H.C., & Orn, H. (1978). 14-year outcome in early schizophrenia. Acta Psychiatrica Scandinavia, 58, 327–338.Google Scholar
  12. Bleuler, E. (1950). Dementia praecox or the group of schizophrenias. (J. Zinkin, Trans.). New York: International University Press. ( Original work published, 1911 ).Google Scholar
  13. Bleuler, M. (1972). Die Schizophrenen Geistestorungen im Lichte langjährigem Kranken—und Familiengeschichten. Stuttgart: George Thieme.Google Scholar
  14. Bleuler, M. (1978). The Schizophrenic Disorders; The Long Term Patient and Family Studies. (S.M. Clemens, Trans.). New Haven: Yale University Press. ( Original work published 1972 ).Google Scholar
  15. Bogerts, B., Ashtari, M., Degreff, G., Alvir, J.M., Bilder, R.M., & Lieberman, J.A. (1990). Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Research, 35, 1–13.PubMedGoogle Scholar
  16. Bracha, H.S., Torrey, E.F., Bigelow, L.B., Lohr, J.B., & Linington, B.B. (1991). Subtle signs of prenatal maldevelopment of the hand ectoderm in schizophrenia: A preliminary monozygotic twin study. Biological Psychiatry, 30, 719–725.Google Scholar
  17. Bridge, T.P., Cannon, H.E., & Wyatt, R.J. (1978). Burned-out schizophrenia: Evidence for age effects on schizophrenic symptomatology. Journal of Gerontology, 33, 312–318.Google Scholar
  18. Brown, G.W., Birley, J.L.T., & Wing, J.K. (1972). Influence of family life on the course of schizophrenic disorders: A replication. British Journal of Psychiatry, 121, 241–258.PubMedGoogle Scholar
  19. Cannon, T.D., Mednick, S.A., & Parnas, J. (1990). Antecedents of predominantly negative- and predominantly positive-symptom schizophrenia in a high-risk population. Archives of General Psychiatry, 47, 622–632.PubMedGoogle Scholar
  20. Cannon-Spoor, E., Potkin, S.G., & Wyatt, R.J. (1982). Measurement of premorbid adjustment in chronic schizophrenia. Schizophrenia Bulletin, 8, 470–484.PubMedGoogle Scholar
  21. Carpenter, W.T., & Kirkpatrick, B. (1988). The heterogeneity of the long-term course of schizophrenia. Schizophrenia Bulletin, 14, 645–652.PubMedGoogle Scholar
  22. Carpenter, W.T., Strauss, J.S., Pulver, A.E., & Wolznier, P.S. (1991). The prediction of outcome in schizophrenia: IV. Eleven-year follow-up of the Washington IPSS cohort. Journal of Nervous and Mental Disease, 179 (9), 517–525.PubMedGoogle Scholar
  23. Casey, D.E., & Hansen, T.E. (1984). Spontaneous dyskinesias. In D.V. Jeste & R.J. Wyatt (Eds.), Neuropsychiatric movement disorders (pp. 68–95 ). Washington, DC: American Psychiatric Press.Google Scholar
  24. Chugani, H.T. (1992). Development of regional brain glucose metabolism in relation to behavior and plasticity. In G. Dawson & K. Fischer (Eds.), Human behavior and the developing brain (pp. 120–135 ). New York: Guilford Press.Google Scholar
  25. Chugani, H.T., Mazziotta, J.C., & Phelps, M.E. (1987). Positron emission tomography study of human brain functional development. Annals of Neurology, 22, 487–497.PubMedGoogle Scholar
  26. Chugani, H.T., & Phelps, M.E. (1986). Maturational changes in cerebral function in infants determined by 18FDG positron emission tomography. Science, 231, 840–843.PubMedGoogle Scholar
  27. Ciompi, L. (1980). Catamnestic long-term study on the course of life and aging of schizophrenics. Schizophrenia Bulletin, 6, 606–618.PubMedGoogle Scholar
  28. Ciompi, L., & Muller, C. (1976). Lebensweg und Alter Schizophrenen eine Katamnestic Longzeitstudie bis ins Senium. Berlin: Springer-Verlag.Google Scholar
  29. Coffey, Y.P., & Jessup, W. (1959). Maternal influenza and congenital deformities: A prospective study. Lancet, 2, 935–938.PubMedGoogle Scholar
  30. Cohen, C.I. (1990). Outcome of schizophrenia into later life: An overview. The Gerontologist, 30 (6), 790–797.PubMedGoogle Scholar
  31. Cross, A.J., Crow, T.J., & Owen, F. (1981). 3H-Flupenthixol binding in postmortem brains of schizophrenics: Evidence for a selective increase in dopamine D2 receptors. Psychopharmacology, 74, 122–124.Google Scholar
  32. Crow, T.J., Johnstone, E.C., Longden, A.J., & Owen, F. (1978). Dopaminergic mechanisms in schizophrenia: The antipsychotic effect and the disease process. Life Sciences, 23, 563–567.PubMedGoogle Scholar
  33. Crow, T.J., MacMillan, J.F., Johnson, A.L., & Johnstone, E.C. (1986). A randomized controlled trial of prophylactic neuroleptic treatment. British Journal of Psychiatry, 148, 120–127.PubMedGoogle Scholar
  34. Cummins, H., & Mildo, C. (1943). Fingerprints, palms and soles: An introduction to dermatoglyphics. New York: Dover.Google Scholar
  35. Dworkin, R.H., Friedman, R., Kaplansky, L.M., Lewis, J.A., Rinaldi, A., Shilliday, G., Cornblatt, B.A., & Erlenmeyer-Kimling, L. ( 1991, December). Childhood precursors of affective and social deficits in adolescents at risk for schizophrenia. Paper presented at the meeting of the Society for Research in Psychopathology, Cambridge, MA.Google Scholar
  36. Dworkin, R.H., Green, S.R., Small, N.E., Warner, M.L., Cornblatt, B.A., & Erlenmeyer-Kimling, L. (1990). Positive and negative symptoms and social competence in adolescents at risk for schizophrenia and affective disorder. Clinical and Research Reports, 147 (9), 1234–1236.Google Scholar
  37. Engelhardt, D.M., Rosen, B., Feldman, J., Engelhardt, J.A.Z., & Cohen, P.A. (1982). A 15-year follow-up of 646 schizophrenic outpatients. Schizophrenia Bulletin, 8, 493–503.PubMedGoogle Scholar
  38. Erlenmeyer-Kimling, L., Marcuse, Y., Cornblatt, B., Friedman, D., Rainer, J.D., & Rutschmann, J. (1984). The New York High-Risk Project. In N.F. Watt, E.J. Anthony, L.C. Wynne, & J. Roff (Eds.), Children at risk for schizophrenia: A longitudinal perspective (pp. 169–189 ). New York: Cambridge University Press.Google Scholar
  39. Falkai, P., & Bogerts, B. (1986). Cell loss in the hippocampus of schizophrenics. European Archives of Psychiatry and Neurological Science, 236, 154–161.Google Scholar
  40. Feinberg, I. (1982-1983). Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence. Journal of Psychiatric Research, 17, 319–334.Google Scholar
  41. Fenton, W.S., & McGlashan, T.H. (1987). Sustained remission in drug-free schizophrenics. American Journal of Psychiatry, 144, 1306–1309.PubMedGoogle Scholar
  42. Fish, B., Marcus, J., Hans, S.L., Auerbach, J.G., & Perdue, S. (1992). Infants at risk for schizophrenia: Sequelae of a genetic neurointegrative defect: A review and replication analysis of pandysmaturation in the Jerusalem Infant Development Study. Archives of General Psychiatry, 49, 221–235.PubMedGoogle Scholar
  43. Freide, R.L. (1989). Developmental neuropathology. Berlin: Springer-Verlag.Google Scholar
  44. Gluck, L. (1977). Intrauterine asphyxia in the developing fetal brain. Chicago: Year Book.Google Scholar
  45. Goldman-Rakic, P.S. (1987). Development of cortical circuitry and cognitive function. Child Development, 58, 601–622.PubMedGoogle Scholar
  46. Goldstein, J.M., & Kreisman, D. (1988). Gender, family environment and schizophrenia. Psychological Medicine, 18, 861–872.PubMedGoogle Scholar
  47. Gossey, S., Golaire, M.C., & Larroche, J.C. (1982). Cerebral, renal, and splenic lesions due to fetal anoxia and their relationship to malformations. Developmental Medicine and Child Neurology, 24, 510–518.Google Scholar
  48. Gottesman, I.I. (1991). Schizophrenia genesis. New York: W.H. Freeman.Google Scholar
  49. Gur, R.E., Resnick, S.M., Alavi, A., Gur, R.C., Caroff, S., Dann, R., Silver, F.L., Saykin, A.J., Chawluk, J.B., Kushner, M., & Reivich, M. (1987). Regional brain function in schizophrenia: A positron emission tomography study. Archives of General Psychiatry, 44, 119–125.PubMedGoogle Scholar
  50. Gur, R.E., Resnick, S.M., Gur, R.C., Alavi, A., Caroff, S., Kushner, M., & Reivich, M. (1987). Regional brain function in schizophrenia: Repeated evaluation with positron emission tomography. Archives of General Psychiatry, 44, 126–129.PubMedGoogle Scholar
  51. Gureje, O. (1988). Topographic subtypes of tardive dyskinesia in schizophrenic patients less than 60 years. Journal of Neurology, Neurosurgery and Psychiatry, 51, 1525–1530.Google Scholar
  52. Guttman, E. (1936). On some constitutional aspects of chorea and on its sequela. Journal of Neurology and Psychopathology, 17, 16–26.Google Scholar
  53. Hamilton, W.J., Boyd, J.D., & Mossman, H.W. (1972). Human embryology: Prenatal development of form and function. London: Heffer.Google Scholar
  54. Hans, S.L., & Marcus, J. (1991). Neurobehavioral development of infants at risk for schizophrenia. In E. Walker (Ed.), Schizophrenia: A life-course developmental perspective (pp. 35 - 53 ). New York: Academic Press.Google Scholar
  55. Harding, C.M. (1988). Course types in schizophrenia: An analysis of European and American studies. Schizophrenia Bulletin, 14, 633–643.PubMedGoogle Scholar
  56. Harding, C.M. (1991). Aging and schizophrenia: Plasticity, reversibility, and/or compensation. In E. Walker (Ed.), Schizophrenia: A life-course developmental perspective (pp. 257–273 ). New York: Academic Press.Google Scholar
  57. Harding, C.M., Brooks, G.W., Ashikaga, T., Strauss, J.S., & Breier, A. (1987a). The Vermont longitudinal study of persons with severe mental illness: I. Methodology, study sample, and overall status 32 years later. American Journal of Psychiatry, 144, 718–726.PubMedGoogle Scholar
  58. Harding, C.M., Brooks, G.W., Ashikaga, T., Strauss, J.S., & Breier, A. (1987b). The Vermont longitudinal study of persons with severe mental illness: II. Long- term outcome for subjects who retrospectively met DSM-III criteria for schizophrenia. American Journal of Psychiatry, 144, 727–735.PubMedGoogle Scholar
  59. Harper, P.S. (Ed.). (1991). Huntington’s disease. London: W.B. Saunders.Google Scholar
  60. Hayashi, M., Satoh, J., Sakamoto, K., & Morimatsu, Y. (1991). Clinical and neuropathological findings in severe athetoid cerebral palsy. Brain and Development, 13, 47–51.PubMedGoogle Scholar
  61. Heaton, R.K., & Drexler, M. (1987). Clinical neuropsychological findings in schizophrenia and aging. In N.E. Miller & G.D. Cohen (Eds.), Schizophrenia and aging. New York: Guilford Press.Google Scholar
  62. Heckers, S., Heinsen, H., Heinsen, Y., & Beckmann, H. (1991). Cortex, white matter, and basal ganglia in schizophrenia: A volumetric postmortem study. Biological Psychiatry, 29, 143–149.Google Scholar
  63. Hertzig, M.E., & Birch, H.G. (1966). Neurologic organization in psychiatrically disturbed adolescent girls. Archives of General Psychiatry, 15, 590–598.PubMedGoogle Scholar
  64. Hess, E.J., Bracha, H.S., Kleinman, J.E., & Creese, I. (1987). Dopamine receptor subtype imbalance in schizophrenia. Life Science, 40, 1487–1497.Google Scholar
  65. Huber, G., Gross, G., & Schuttler, R. (1979). Schizophrenie. Verlaufs-und sozialpsychiatrische Langzeitunter-suchungen an den 1945 his 1959 in Bonn hospitalisierten schizophrenen Kranken. Monographien aus dem Gesamtgebiete der Psychiatrie. Bd. 21. Berlin: Springer-Verlag.Google Scholar
  66. Huttenlocher, P.R. (1990). Morphometric study of human cerebral cortex development. Neuropsychologia, 28, 517–527.PubMedGoogle Scholar
  67. Izard, C.E., Dougherty, L.M., & Hembree, E.A. (1983). A System for identifying affect expressions by holistic judgements (AFFEX). Neward, DE: Instructional Resources Center, University of Delaware.Google Scholar
  68. Jakob, H., & Beckman, H. (1986). Prenatal development disturbances in the limbic allocortex in schizophrenics. Journal of Neural Transmission, 65, 303–326.PubMedGoogle Scholar
  69. Jernigan, T.L., Zisook, S., Heaton, R.K., Moranville, J.T., Hesselink, J.R., & Braff, D.L. (1991). Magnetic resonance imaging abnormalities in lenticular nuclei and cerebral cortex in schizophrenia. Archives of General Psychiatry, 48, 881–890.PubMedGoogle Scholar
  70. Jeste, D.V., & Lohr, J.B. (1989). Hippocampal pathologic findings in schizophrenia. Archives of General Psychiatry, 46, 1019–1026.PubMedGoogle Scholar
  71. Jeste, D.V., & Wyatt R.J. (1987). Aging and tardive dyskinesia. In N. Miller & G. Cohen (Eds.), Schizophrenia and aging (pp. 275–283 ). New York: Guilford Press.Google Scholar
  72. John, R.S., Mednick, S.A., & Schulsinger, F. (1982). Teacher reports as a predictor of schizophrenia and borderline schizophrenia: A Bayesian decision analysis. Journal of Abnormal Psychology, 91 (6), 399–413.PubMedGoogle Scholar
  73. Johnstone, E.C., Crow, T.J., Johnson, A.L., & MacMillan, J.F. (1986). The North wick Park Study of first episodes of schizophrenia: I. Presentation of the illness and problems relating to admission. British Journal of Psychiatry, 148, 115–120.PubMedGoogle Scholar
  74. Johnstone, E.C., MacMillan, J.F., Frith, C.D., Benn, D.K., & Crow, T.J. (1990). Further investigation of predictors of outcome following first schizophrenic episodes. British Journal of Psychiatry, 157, 182–189.PubMedGoogle Scholar
  75. Jonsson, H., & Nyman, A.K. (1991). Predicting long-term outcome in schizophrenia. Acta Psychiatrica Scandinavia, 83, 342–346.Google Scholar
  76. Kay, S.R., Fiszbein, A., & Opler, A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13 (2), 261–276.PubMedGoogle Scholar
  77. Kay, S.R., & Murrill, L.M. (1990) Predicting outcome of schizophrenia: Significance of symptom profiles and outcome dimensions. Comprehensive Psychiatry, 31, 91–102.PubMedGoogle Scholar
  78. Kennard, M.A. (1960). Value of equivocal signs in neurologic diagnosis. Neurology, 10, 753–764.PubMedGoogle Scholar
  79. Khot, V., & Wyatt, R.J. (1991). Not all that moves is tardive dyskinesia. American Journal of Psychiatry, 148, 661–666.PubMedGoogle Scholar
  80. Kidger, T., Barnes, T.R.E., Trauer, T., & Taylor, P.J. (1980). Subsyndromes of tardive dyskinesia. Psychological Medicine, 10, 513–520.PubMedGoogle Scholar
  81. Klawans, H.L. (1988). The pathophysiology of drug-induced movement disorders. In J. Jankonic & E. Tolosa (Eds.), Parkinson’s disease and movement disorder (pp. 315–324 ). Baltimore: Urban and Schagenberg.Google Scholar
  82. Klawans, H.L., & Weiner, W.J. (1975). The pharmacology of choreatic movement disorders. In G.A. Kerkut & J.W. Philips (Eds.), Progress in neurobiology (pp. 1–32 ). Oxford, England: Pergamon Press.Google Scholar
  83. Knobloch, H., & Pasamanick, B. (1974). Developmental diagnosis. New York: Harper & Row.Google Scholar
  84. Konner, M. (1991). Universals of behavioral development in relation to brain myelination. In K. Gibson & A. Peterson (Eds.), Brain maturation and cognitive development (pp. 181–224 ). New York: Aldine De Gruyter.Google Scholar
  85. Kovelman, J., & Scheibel, A. (1984). A neurohistological correlate of schizophrenia. Biological Psychiatry, 19, 1601–1621.PubMedGoogle Scholar
  86. Leck, T. (1963). Incidence of malformations following influenza symptoms. British Journal of Preventative and Social Medicine, 17, 70–73.Google Scholar
  87. Lewine, R.R.J. (1991). Ontogenetic implications of Sex Differences in Schizophrenia. In E. Walker (Ed.), Schizophrenia: A life-course developmental perspective. New York: Academic Press.Google Scholar
  88. Lewis, & Murray. (1987). Obstetric Complications, neurodevelopmental deviance and risk of schizophrenia. Journal of Psychiatric Research, 21, 413–421.PubMedGoogle Scholar
  89. Lindenmeyer, J., Kay, S.R., & Opler, L. (1984). Positive and negative subtypes in acute schizophrenia. Comprehensive Paychiatry, 25 (4), 455–464.Google Scholar
  90. Loranger, A. (1984). Sex differences in age at onset of schizophrenia. Archives of General Psychiatry, 41, 157–161.PubMedGoogle Scholar
  91. Lyon, M., Barr, C.E., Cannon, T.D., Mednick, S.A., & Shore, D. (1989). Fetal neural development and schizophrenia. Schizophrenia Bulletin, 15, 149–160.PubMedGoogle Scholar
  92. Machon, R.A., Mednick, S.A., & Schulsinger, F. (1987). Seasonality, birth complications, and schizophrenia in a high risk sample. British Journal of Psychiatry, 151, 122–124.PubMedGoogle Scholar
  93. MacMillan, J.F., Gold, A., Crow, T.J., Johnson, A.L., & Johnstone, E.C. (1986). The Northwick Park Study of first episodes of schizophrenia: IV. Expressed emotion and relapse. British Journal of Psychiatry, 148, 133–143.PubMedGoogle Scholar
  94. Marneros, A., Deister, A., & Rohde, A. (1992). Validity of the negative /positive dichotomy for schizophrenic disorders under long-term conditions. Schizophrenia Research, 7, 117–123.PubMedGoogle Scholar
  95. McGeer, P.L., McGeer, E.G. (1981). Neurotransmitters in the aging brain. In A.M. Darrison & R.M. Thompson (Eds.), The nolecular basis of neuropathology (pp. 631–648 ). London: Edward Arnold Ltd.Google Scholar
  96. McGlashan, T.H. (1984a). The Chestnut Lodge follow-up study: I. Follow-up methodology and study sample. Archives of General Paychiatry, 41, 573–585.Google Scholar
  97. McGlashan, T.H. (1984b). The Chestnut Lodge follow-up study: II. Longterm outcome of schizophrenia and the affective disorders. Archives of General Psychiatry, 41, 586–601.PubMedGoogle Scholar
  98. McGlashan, T.H. (1986). Predictors of shorter-, medium-, and longer-term outcome in schizophrenia. American Journal of Psychiatry, 143, 50–55.PubMedGoogle Scholar
  99. McGlashan, T.H. (1988). A selective review of recent North American long-term followup studies of schizophrenia. Schizophrenia Bulletin, 14, 515–542.PubMedGoogle Scholar
  100. McNeil, T.F. (1987). Perinatal influences in the development of schizophrenia. In H. Helmehen & F.A. Henn (Eds.), Biological perspective of schizophrenia. (pp. 125–138 ).Google Scholar
  101. McNeil, T.F., & Kaij, L. (1978). Obstetric factors in the development of schizophrenia: Complications in the births of preschizophrenice and in reproduction by schizophrenic parents. In L.C. Wynne, R.L. Cromwell, & S. Matthysee (Eds.), The nature of schizophrenia (pp. 401–429 ), New York: John Wiley and Sons Limited.Google Scholar
  102. Mednick, S., Machon, R.A., Huttunen, M.O., & Bonnett, D. (1988). Adult schizophrenia following prenatal exposure to an influenza epidemic. Archives of General Psychiatry, 45, 15–23.Google Scholar
  103. Mednick, S.A., & Schulsinger, F. (1965). A longitudinal study of children with a high risk for schizophrenia: A preliminary report. In S. Vandenberg (Ed.), Methods and goals in human behavior genetics (pp. 255–296 ). New York: Academic Press.Google Scholar
  104. Miller, N.E., & Cohen, G.D. (Eds.) (1987). Schizophrenia and Aging. New York: The Guilford Press.Google Scholar
  105. Narabayashi, H. (1989). Striatal symptoms. Stereotactic Functional Neurosurgery, 52, 200–204.Google Scholar
  106. Newell-Morris, L.L., Fahrenbruch, C.E., Sackett, G.P. (1989). Prenatal psychological stress, dermatoglyphic asymmetry and pregnancy outcome in the pigtailed macaque (Macaca nemestrina). Biology of the Neonate, 56, 61–75.PubMedGoogle Scholar
  107. O’Callaghan, E., Sham, P., Takei, N., Glover, G., & Murray, R.M. (1991). Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic. Lancet, 337, 1248–1250.PubMedGoogle Scholar
  108. Obrist, W.D. (1980). Cerebral blood flow and EEG changes associated with aging and dementia. In E.W. Busse & D.G. Blazer (Eds.), Handbook of geriatric psychiatry (pp. 83–101 ). New York: Van Nostrand Reinhold.Google Scholar
  109. O’Gureje, O. (1989). Correlates of positive and negative schizophrenic syndromes in Nigerian patients. British Journal of Psychiatry, 155, 628–632.Google Scholar
  110. Ojordsmoen, S. (1991). Long-term clinical outcome of schizophrenia with special reference to gender differences. Acta Psychiatrica Scandinavia, 83, 307–313.Google Scholar
  111. Opler, L.A., Kay, S.R., Rosado, V., & Lindenmeyer, J. (1984). Positive and negative syndromes in chronic schizophrenic inpatients. Journal of Nervous and Mental Disease, 172 (6), 317–324.PubMedGoogle Scholar
  112. Parnas, J., Schulsinger, F., Teasdale, T.W., Schulsinger, H., Feldman, P.M., & Mednick, S.A. (1982). Perinatal complications and clinical outcome with the schizophrenia spectrum. British Journal of Psychiatry, 340, 416–420.Google Scholar
  113. Pogue-Guile, M.F., & Harrow, M. (1984). Negative and positive symptoms in schizophrenia and depression: A follow-up. Schizophrenia Bulletin, 10 (3), 371–387.Google Scholar
  114. Pogue-Guild, M.F., & Harrow, M. (1985). Negative symptoms in schizophrenia: Their longitudinal course and prognostic importance. Schizophrenia Bulletin, 11 (3), 427–439.Google Scholar
  115. Rabiner, C.J., Wegner, J.T., & Kane, J.M. (1986). Outcome study of first episode psychosis: I. Relapse rate after one year. American Journal of Psychiatry, 143, 1155–1158.PubMedGoogle Scholar
  116. Rakic, P. (1988). Defects of neuronal migration and the pathogenesis of cortical malformations. Progress in Brain Research, 73, 15–35.PubMedGoogle Scholar
  117. Ram, R., Bromet, E.J., Eaton, W., Pato, E.C., & Schwartz, J.E. (1992). The natural course of schizophrenia: A review of first-admission studies. Schizophrenia Belletin, 18, 185–207.Google Scholar
  118. Rappaport, M., Hopkins, H.K., Hall, K., Belleza, T., & Silverman, J. (1978). Are there schizophrenics for whom drugs may be unnecessary of contrain- dicated? International Pharmacopsychiatry, 13, 100–111.PubMedGoogle Scholar
  119. Reich, J., & Thompson, W.D. (1985). Marital status of schizophrenic and alcoholic patients. The Journal of Nervous and Mental Disease, 173, 499–502.PubMedGoogle Scholar
  120. Reither, P.J. (1926). Extrapyramidal motor-disturbances in dementia praecox. Acta Psychiatrica et Neurologica Scandinavien, 1, 287–309.Google Scholar
  121. Resnick, S.M., Gur, R.E., Alavi, A., Gur, R.C., & Reivich, M. (1988). Positron emission tomography and subcortical glucose metabolism in schizophrenia. Psychiatry Research, 24, 1–11.PubMedGoogle Scholar
  122. Reynolds, G.P. (1983). Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia. Nature, 305, 527–529.PubMedGoogle Scholar
  123. Rochford, J.M., Detre, T., Tucker, G.J., & Harrow, M. (1970). Neuropsychological impairments in functional psychiatric diseases. Archives of General Psychiatry, 22, 114–119.PubMedGoogle Scholar
  124. Roff, J.D., Knight, R., & Wertheim, E. (1976). A factor-analytic study of childhood symptoms antecedent to schizophrenia. Journal of Abnormal Psychology, 85 (6), 543–549.PubMedGoogle Scholar
  125. Rupp, C., & Fletcher, E.K. (1940). A five to ten year follow-up study of 641 schizophrenic cases. American Journal of Psychiatry, 96, 877–888.Google Scholar
  126. Saint-Anne Dargassies, S. (1982). The neuromotor and psychoaffective development of the infant. Amsterdam, the Netherlands: Elsevier.Google Scholar
  127. Salokangas, R.K.R. (1983). Prognostic implications of the sex of schizophrenic patients. British Journal of Psychiatry, 142, 145–151.PubMedGoogle Scholar
  128. Saugstad L. (1989). Social class, marriage and fertility in schizophrenia. Schizophrenia Bulletin, 15, 9–44.PubMedGoogle Scholar
  129. Schaumann, B., & Alter, A. (1976). Dermatoglyphics in medical disorders. New York: Springer-Verlag.Google Scholar
  130. Schwarzkopf, S., Nasrallah, A., Olson, S.C., Coffman, J., & Mclaughlin, J. (1988). Perinatal complications and genetic loading in schizophrenia: Preliminary findings. Psychiatry Research, 27, 233–239.Google Scholar
  131. Scottish Schizophrenia Research Group. (1988). The Scottish first episode schizophrenia study: V. One year follow-up. British Journal of Psychiatry, 152, 470–476.Google Scholar
  132. Seeman, M.V. (1983). Interaction of sex, age, and neuroleptic dose. Comprehensive Psychiatry, 24, 125–128.PubMedGoogle Scholar
  133. Seeman, M.V., & Hauser, P. (1984). Schizophrenia: The influence of gender on family environment. International Journal of Family Psychiatry, 5, 227–232.Google Scholar
  134. Seeman, P., Bzowej, N.H., Guan, H.C., Bergeron, C., Reynolds, G.P., Bird, E.D., Riederer, P., Jellinger, K., & Tourtellotte, W.W. (1987). Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer’s, Parkinson’s, and Huntington’s diseases. Neuropsychopharmacology, 1, 5–15.PubMedGoogle Scholar
  135. Stengel, T.J., Attermeier, S.M., Bly, L., & Heriza, C.B. (1984). Evaluation of sensorimotor dysfunction. In S.K. Campbell (Ed.), Pediatric neurologic physical therapy (pp. 13–81 ). New York: Churchill Livingstone.Google Scholar
  136. Stevens, J.H. (1978). Long-term prognosis and followup in schizophrenia. Schizophrenia Bulletin, 4, 25–47.Google Scholar
  137. Stevens, J.H., & Astrup, C. (1963). Prognosis in “process” and “nonprocess” schizophrenia. American Journal of Psychiatry, 119, 945–953.Google Scholar
  138. Stevens, J.H., Astrup, C., & Mangrum, J.C. (1966). Prognostic factors in recovered and deteriorated schizophrenics. American Journal of Psychiatry, 122, 1116–1121.Google Scholar
  139. Suddath, R.L., Christison, G.W., Torrey, E.F., Casanova, M.F., & Weinberger, D.R. (1990). Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. New England Journal of Medicine, 332, 789–794.Google Scholar
  140. Tamminga, C.A., Thaker, G.K., Buchanan, R., Kirkpatrick, B., Alphs, L.D., Chase, T.N., & Carpenter, W.T. (1992). Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Archives of General Psychiatry, 49, 522–530.PubMedGoogle Scholar
  141. Test, M.A., Burke, S.S., & Wallisch L.S. (1990). Gender differences of young adults with schizophrenic disorders in community care. Schizophrenia Bulletin, 16 (2), 331–344.PubMedGoogle Scholar
  142. Toru, M., Watanabe, S., Shibuya, H., Nishikawa, T., Noda, K., Mitsushio, H., Ichikawa, H., Kurumaji, A., Takaskhima, M., Mataga, N., & Ogawa, A. (1988). Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients. Acta Psychiatrica Scandinavica, 78, 121–137.PubMedGoogle Scholar
  143. Towbin, A. (1986). Obstetric malpractice litigation: The pathologist’s view. American Journal of Obstetrics and Gynecology, 155, 927–935.PubMedGoogle Scholar
  144. Tsuang, M.T., & Winokur, G. (1975). The Iowa 500: Field work in a 35 year follow-up of depression, mania, and schizophrenia. Canadian Psychiatric Journal, 20, 389.Google Scholar
  145. Tsuang, M.T., Woolson, R.F., & Fleming, J.A. (1979). Long-term outcome of major psychosis: I. Schizophrenia and affective disorders compared with psychiatrically symptom-free surgical conditions. Archives of General Psychiatry, 39, 1295–1301.Google Scholar
  146. Ulloa-Aguirre, A., Tarraso, J., Mendez, J.P., Garza-Flores, J., Diaz-Sanchez, V., & Perez-Palacios, G. (1991). Changes in the responsiveness of prolactin secretion to depaminergic blockade and TRH stimulation throughout sexual maturation in men. Psychoneuroendocrinology, 15, 279–286.Google Scholar
  147. Vaillant, G.E. (1964a). An historical review of the remitting schizophrenias. Journal of Nervous and Mental Diseases, 138, 48–56.Google Scholar
  148. Vaillant, G.E. (1964b). Prospective prediction of schizophrenic remission. Archives of General Psychiatry, 11, 509–518.PubMedGoogle Scholar
  149. Vaughn, C., & Leff, J. (1976). The influence of family and social functions on the course of psychiatric illness. British Journal of Psychiatry, 129, 125–137.PubMedGoogle Scholar
  150. Vaughn, C.E., Snyder, K.S., Jones, S., Freeman, W.B., & Falloon, R.H. (1984). Family factors in schizophrenic relapse: Replication in California of British research on expressed emotion. Archives of General Psychiatry, 41, 1169–1177.PubMedGoogle Scholar
  151. Virtunski, P.B., Simpson, D.M., & Meltzer, H.Y. (1989) Voluntary movement dysfunction in schizophrenia. Biological Psychiatry, 25, 529–539.Google Scholar
  152. Waddington, J.L., & Youssef, H.A. (1990). The lifetime outcome and involuntary movements of schizophrenia never treated with neuroleptic drugs: Four rare cases in Ireland. British Journal of Psychiatry, 156, 106–108.PubMedGoogle Scholar
  153. Wakita, Y., Narahara, K., & Kimoto, H. (1988). Multivariate analysis dermato- glyphics of severe mental retardates: An application of the constellation in graphical method for discriminate analysis. Acta Med Okayama, 42, 159–168.PubMedGoogle Scholar
  154. Walker, E., & Emory, E. (1981). Infants at risk for psychopathology: Offspring of schizophrenic parents. Child Development, 54, 1269–1285.Google Scholar
  155. Walker, E., Grimes, K., Davis, D., & Smith, A. (1993). Childhood precursors of schizophrenia: Facial expressions of emotion. American Journal of Psychiatry, 150, 1654–1660.PubMedGoogle Scholar
  156. Walker, E., & Lewine, R. (1988). The positive/negative symptom distinction in schizophrenia: Validity and etiological relevance. Schizophrenia Research, 1, 315–328.PubMedGoogle Scholar
  157. Walker, E., Lucas, M., & Lewine, R. (1992). Schizophrenic disorders. In A. Puente & R. McCaffrey (Eds.), Handbook of neuropsychological assessment: A biopsychosocial perspective (pp. 309–334 ). New York: Plenum Press.Google Scholar
  158. Walker, E., Savoie, T., & Davis, D. (1994). Neuromotor precursors of schizophrenia. Schizophrenia Bulletin, 20, 441–452.PubMedGoogle Scholar
  159. Waring, E.M., Lefese, D.H., Carver, C., Barnes, S., Fry, R., & Abraham, B. (1988). The course and outcome of early schizophrenia. The Psychiatric Journal of the University of Ottawa, 13, 194–197.Google Scholar
  160. Watt, D.C., Katz, K., & Shepherd, M. (1983). The natural history of schizophrenia: A 5-year prospective followup of a representative sample of schizophrenics by means of a standardized clinical and social assessment. Psychological Medicine, 13, 663–670.PubMedGoogle Scholar
  161. Watt, N.F. (1978). Patterns of childhood social development in adult schizophrenics. Archives of General Psychiatry, 35, 160–165.PubMedGoogle Scholar
  162. Watt, N.F., Grubb, T.W., & Erlenmeyer-Kimling, L. (1984). Social, emotional, and intellectual behavior at school among children at high risk for schizophrenia. In N.F. Watt, J. Anthony, L.C. Wynne, & J.E. Rolf (Eds.), Children at risk for schizophrenia (pp. 212–226 ). New York: Cambridge University Press.Google Scholar
  163. Wattie, B.J.S., & Kedward, H.B. (1985). Gender differences in living conditions found among male and female schizophrenic patients on a follow-up study. International Journal of Social Psychiatry, 31, 205–216.PubMedGoogle Scholar
  164. Weggmann, T., Brown, J.K., Fulford, G.E., & Minns, R.A. (1987). A study of normal baby movements. Child: Care, Health, and Development, 13, 41–58.Google Scholar
  165. Weinberger, D. (1987). Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry, 44, 660–669.PubMedGoogle Scholar
  166. Wilcox. J.A. (1990). Thought disorder and relapse in schizophrenia. Pscyhopathology, 23, 153–156.Google Scholar
  167. Wilcox, J.A., & Nasrallah, H.A. (1987). Perinatal distress and prognosis of psychotic illness. Neuropsychobiology, 17, 173–175.PubMedGoogle Scholar
  168. Winblad, B., Hardy, J., Backman, L., & Nilsson, L.G. (1985). Memory function and brain biochemistry in normal aging and in senile dementia. Annals of the New York Academy of Science, 444, 255–268.Google Scholar
  169. Winokur, G., Pfohl, B., & Tsuang, M. (1987). A 40-year follow-up of hebephrenic- catatonic schizophrenia. In N.E. Miller & G.D. Cohen (Eds.), Schizophrenia and aging. New York: Guilford Press.Google Scholar
  170. Wong, D.F., Wagner, H.N., Jr., Tune, L.E., Dannals, R.F., Pearlson, G.D., Links, J.M., Tamminga, C.A., Brosusolle, E.P., Ravert, H.T., Wilson, A.A., Toung, J.K.T., Malat, J., Williams, J.A., O’Tuama, L.A., Snyder, S.H., Kuhar, M.J., & Gjedde, A. (1986). Positron emission tomography reveals elevated D2 dopamine receptors in neuroleptic-naive schizophrenics. Science, 234, 1558–1563; correction (1987) 235, 623.Google Scholar
  171. Wyatt, N. (1991). Neuroleptics and the natural course of schizophrenia. Schizophrenia Bulletin, 17, 325–351.PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1995

Authors and Affiliations

  • Elaine Walker
  • Dana Davis
  • Jay Weinstein
  • Tammy Savoie
  • Kathleen Grimes
  • Kym Baum

There are no affiliations available

Personalised recommendations